Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 4c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q2 EPS of ($0.42), $0.04 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $3.46 million versus the consensus estimate of $3.05 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Meta unveils lower-priced AI smart glasses starting at $299
• TEN Holdings files for 5 million share offering at $1.25 per share